Australia’s notifiable disease status, 2013: Annual report of the National Notifiable Diseases Surveillance System: Part 11

The National Notifiable Diseases Surveillance System monitors the incidence of an agreed list of communicable diseases in Australia. This report analyses notifications during 2013.

Page last updated: 16 October 2015

Acknowledgements

The authors wish to thank the following people for their contribution to this report.

Rachel de Kluyver, Office of Health Protection

Members of the National Surveillance Committee

The National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

Author details

Coordinating author: Rachel de Kluyver

Data management: Mark Trungove

Bloodborne diseases: Amy Bright, Carolyn Konrad

Gastrointestinal diseases: Ben Polkinghorne, Fiona May

Quarantinable diseases: Katrina Knope

Sexually transmissible infections: Amy Bright, Carolyn Konrad

Vaccine preventable diseases: Nicolee Martin, Cindy Toms, Rachel de Kluyver

Vectorborne diseases: Katrina Knope

Zoonoses: Katrina Knope, Fiona May

Other bacterial infections: Cindy Toms, Anna Glynn-Robinson

Top of page

With contributions from:

National organisations

Communicable Diseases Network Australia and subcommittees

Australian Childhood Immunisation Register

Australian Gonococcal Surveillance Programme

Australian Meningococcal Surveillance Programme

Australian Sentinel Practice Research Network

Australian Quarantine Inspection Service

The Kirby Institute

National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

National Enteric Pathogens Surveillance Scheme

OzFoodNet Working Group

World Health Organization Collaborating Centre for Reference and Research on Influenza

State and territory health departments

Communicable Diseases Control, ACT Health, Australian Capital Territory

Communicable Diseases Surveillance and Control Unit, NSW Ministry of Health, New South Wales

Centre for Disease Control, Northern Territory Department of Health and Community Services, Northern Territory

Communicable Diseases Branch, Queensland Health, Queensland

Communicable Disease Control, South Australian Department of Health, South Australia

Communicable Diseases Prevention Unit, Department of Health and Human Services, Tasmania

Health Protection Branch, Department of Health, Victoria

Communicable Diseases Control Directorate, Department of Health, Western Australia

Top of page

Abbreviations

7vPCV 7 valent pneumococcal conjugate vaccine

13vPCV 13 valent pneumococcal conjugate vaccine

23vPPV 23 valent pneumococcal polysaccharide vaccine

ABLV Australian bat lyssavirus

AFP acute flaccid paralysis

AGSP Australian Gonococcal Surveillance Programme

AIDS acquired immune deficiency syndrome

AMSP Australian Meningococcal Surveillance Programme

ANCJDR Australian National Creutzfeldt-Jakob Disease Registry

BCG bacillus Calmette–Guérin

BFV Barmah Forest virus

CDI Communicable Diseases Intelligence

CDNA Communicable Diseases Network Australia

CDWG Case Definitions Working Group

CJD Creutzfeldt-Jakob disease

CRS congenital rubella syndrome

DENV dengue virus

Hib Haemophilus influenzae type b

HIV human immunodeficiency virus

HPAIH highly pathogenic avian influenza in humans

HUS haemolytic uraemic syndrome

ILI influenza like illness

IMD invasive meningococcal disease

IPD invasive pneumococcal disease

JEV Japanese encephalitis virus

KUNV Kunjin virus

MenCCV meningococcal serogroup C vaccine

MMR measles-mumps-rubella

MMRV measles-mumps-rubella-varicella

MVEV Murray Valley encephalitis virus

NDP no data provided

NEC not elsewhere classified

NIP National Immunisation Program

NN not notifiable

NNDSS National Notifiable Diseases Surveillance System

NQFMP National Q Fever Management Program

NSC National Surveillance Committee

NS1 non-structural protein 1

PCR polymerase chain reaction

RRV Ross River virus

SARS severe acute respiratory syndrome

STEC Shiga toxin-producing Escherichia coli

STI(s) sexually transmissible infections(s)

TB tuberculosis

VPD(s) vaccine preventable disease(s)

VTEC verotoxigenic Escherichia coli

VZV varicella zoster virus

WHO World Health Organization

WHOCC World Health Organization Collaborating Centre for Reference and Research on Influenza

Top of page

References

  1. National Health Security Act, 2007. Accessed on March 2015. Available from: http://www.legislation.gov.au/Details/C2007A00174
  2. National Health Security (National Notifiable Disease List) Instrument 2008. Accessed on March 2015. Available from: http://www.legislation.gov.au/ComLaw/legislation/LegislativeInstrument1.nsf/0/7162D634C6DD1BAACA25740B0079D6B8?OpenDocument
  3. National Health Security Agreement 2008. Accessed on March 2015. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-nhs-agreement.htm
  4. The Kirby Institute. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report, 2012: The Kirby Institute, the University of New South Wales, Sydney; 2012.
  5. Klug GM, Boyd A, McGlade A, Stehmann C, Simpson M, Masters CL, et al. Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2011. Commun Dis Intell 2012;36(2):E174–E179.
  6. Communicable Diseases Network Australia. National Notifiable Diseases Surveillance System. 2013. Accessed on March 2015. Available from: www.health.gov.au/nndssdata
  7. Australian Bureau of Statistics. Australian Demographic Statistics. Canberra: Australian Bureau of Statistics; 2011. Report No.: 3101.0.
  8. Australian Institute of Health and Welfare. Age-standardised rate—Identifying and definitional attributes. 2005. Accessed on 17 March 2010. Available from: http://meteor.aihw.gov.au/content/index.phtml/itemId/327276
  9. Graham S, Guy RJ, Donovan B, McManus H, El-Hayek C, Kwan K, et al. Epidemiology of chlamydia and gonorrhea among Indigenous and non-Indigenous Australians, 2000–2009. Med J Aust 2012;197(11):642–646.
  10. Hammerschlag M. Sexually transmitted diseases in sexually abused children: medical and legal implications. Sex Transm Infect 1998;74(3):167–174.
  11. Australian Institute of Health and Welfare. National Health Data Dictionary 13.3; 2008.
  12. Chen MY, Fairley CK, Donovan B. Nowhere near the point of diminishing returns: correlations between chlamydia testing and notification rates in New South Wales. Aust N Z J Public Health 2005;29(3):249–253.
  13. Hocking J, Fairley C, Counahan M, Crofts N. The pattern of notification and testing for genital Chlamydia trachomatis infection in Victoria, 1998–2000: an ecological analysis. Aust N Z J Public Health 2003;27(4):405–408.
  14. Burckhardt F, Warner P, Young H. What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection? Sex Transm Infect 2006;82(1):24–30.
  15. Chen MY, Karvelas M, Sundararajan V, Hocking JS, Fairley CK. Evidence for the effectiveness of a chlamydia awareness campaign: increased population rates of chlamydia testing and detection. Int J STD AIDS 2007;18(4):239–243.
  16. Hammad A, Guy RJ, Fairley C, Wand H, Chen MY, Dickson B, et al. Understanding trends in genital Chlamydia trachomatis can benefit from enhanced surveillance: findings from Australia. Sex Transm Infect 2012;88(7):552–557.
  17. Stephens N, O’Sullivan M, Coleman D, Shaw K. Chlamydia trachomatis in Tasmania 2001–2007: rising notification trends. Aust N Z J Public Health 2010;34(2):120–125.
  18. Communicable Diseases Network Australia. Australian national notifiable diseases case definitions. 2015. Accessed on 5 September 2014. Available from: http://www.health.gov.au/casedefinitions
  19. National HBV Testing Policy Expert Reference Committee. National hepatitis B testing policy 2012 v1.1. ASHM, Darlinghurst, NSW: Commonwealth of Australia; 2012.
  20. National HCV Testing Policy Expert Reference Committee. National hepatitis C testing policy 2012 v1.1. ASHM, Darlinghurst, NSW: Commonwealth of Australia; 2012.

Top of page

  1. Heymann DL. Control of Communicable Diseases Manual. 19th edn. Washington: American Public Health Association, USA; 2008.
  2. National Centre for Immunisation Research and Surveillance. Hepatitis B vaccines for Australians, NCIRS fact sheet: July 2015. Accessed on July 2015. Available from: http://www.ncirs.edu.au/assets/provider_resources/fact-sheets/hepatitis-B-fact-sheet.pdf
  3. Medicare Australia. Australian Childhood Immunisation Register — Statistics. 2014. Accessed on March 2015. Available from: http://www.medicareaustralia.gov.au/provider/patients/acir/statistics.jsp
  4. Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 2007;25(51):8637–8641.
  5. National Centre for Immunisation Research and Surveillance. Significant events in hepatitis B vaccination practice in Australia. 2015. Accessed on July 2015. Available from: http://www.ncirs.edu.au/assets/provider_resources/history/Hepatitis-B-history-July-2015.pdf
  6. Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell 2010;34(Suppl):S1–S172.
  7. Maclachlan JH, Towell T, Cowie BC. The burden of chronic hepatitis B virus infection in Australia, 2011. Aust N Z J Public Health 2013;37(5):416–422.
  8. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2014; 2014.
  9. Butler T, Lim D, Callander D. National Prison Entrants’ Bloodborne Virus and Risk Behaviour Survey Report 2004, 2007 and 2010. Prevalence of HIV, hepatitis C, hepatitis B, sexually transmissible infections, and risk behaviours among Australian prison entrants; 2011.
  10. Razali K, Thein HH, Bell J, Cooper-Stanbury M, Dolan K, Dore G, et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007;91(2–3):228–235.
  11. Ward K, Franklin N, Furlong C, Polkinghorne B, Flint J. NSW 2013 OzFoodNet annual report. Sydney: NSW Ministry of Health; 2013.
  12. OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: Annual report of the OzFoodNet Network, 2010. Commun Dis Intell 2012;36(3):E213–E241.
  13. Donnan EJ, Fielding JE, Gregory JE, Lalor K, Rowe S, Goldsmith P, et al. A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009. Clin Infect Dis 2012;54(6):775–781.
  14. Cumpston JHL. Health and disease in Australia. Canberra: Australian Government Publishing Service; 1989.
  15. Grattan-Smith PJ, O’Regan WJ, Ellis PS, O’Flaherty SJ, McIntyre PB, Barnes CJ. Rabies. A second Australian case with a long incubation period. Med J Aust 1992;156(9):651–654.
  16. Fenner F, Henderson D, Arita I, Jezek Z, Ladnyi I. Smallpox and its eradication. Geneva, Switzerland; 1988.
  17. Australian Government Department of Health and Ageing. Guidelines for smallpox outbreak, preparedness, response and management. 2004. Accessed on March 2015. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-publicat-document-metadata-smallpox.htm
  18. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2011: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2013;37(4):E313–E393.
  19. Miller M, Roche P, Yohannes K, Spencer J, Bartlett M, Brotherton J, et al. Australia’s notifiable diseases status, 2003: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2005;29(1):1–61.
  20. World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. 2013. Available from: http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html

Top of page

  1. Curran M, Harvey B, Crerar S. Annual report of the National Notifiable Diseases Surveillance System, 1996. Commun Dis Intell 1997;21(20):281–307.
  2. Forssman B, Mannes T, Musto J, Gottlieb T, Robertson G, Natoli JD, et al. Vibrio cholerae O1 El Tor cluster in Sydney linked to imported whitebait. Med J Aust 2007;187(6):345–347.
  3. Geisler WM, Lensing SY, Press C, Hook Er. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis 2013;207(12):1850–1856.
  4. The Kirby Institute. National Blood-borne Virus and Sexually Transmissible Infections Surveillance and Monitoring Report 2013. Sydney, NSW: The Kirby Institute, the University of New South Wales; 2013.
  5. Victoria Department of Health. Blue book: Guidelines for the control of infectious diseases. 2009. Accessed on 3 April 2014. Available from: http://ideas.health.vic.gov.au/bluebook/
  6. Bowden FJ, on behalf of the National Donovanosis Eradication Advisory Committee. Donovanosis in Australia: going, going... Sex Transm Infect 2005;81(5):365–366.
  7. Lahra MM, Enriquez RP. Australian Meningococcal Surveillance Programme annual report, 2012. Commun Dis Intell 2013;37(3):E224–E232.
  8. Ward J, Guy RJ, Akre S, Middleton M, Giele C, Su J, et al. Epidemiology of syphilis in Australia: moving toward elimination of infectious syphilis from Aboriginal and Torres Strait Islander communities? Med J Aust 2011;194(10):525–529.
  9. Government of Western Australia. Department of Health. The Epidemiology of Notifiable Sexually Transmitted Infections and Blood-Borne Viruses in Western Australia 2009. Perth: Department of Health, Western Australia; 2010.
  10. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th edn. Canberra, Australia: National Health and Medical Research Council and the Department of Health; 2013.
  11. World Health Organization. Measles Vaccines: WHO position paper. Wkly Epidemiol Rec 2009;35(84):349–360.
  12. Punpanich W, Chotpitayasunondh T. A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis 2012;16(10):e714–e723.
  13. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775–785.
  14. Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ 2013;16(2):264–277.
  15. Sosin DM. Draft framework for evaluating syndromic surveillance systems. J Urban Health 2003;80(Suppl 1):8–13.
  16. Turbelin C, Souty C, Pelat C, Hanslik T, Sarazin M, Blanchon T, et al. Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France. PLoS One 2013;8(6):e65919.
  17. de Jong MD, Thanh TT, Khanh TH, Hien VM, Smith GJD, Chau NV, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005;353:2667–2672.
  18. World Health Organization. Review of the 2013 influenza season in the Southern Hemisphere. Wkly Epidemiol Rec 2013;48(88):509–520.
  19. NSW Ministry of Health. Influenza Monthly Epidemiology Report, NSW: December 2013 (including a summary for the year 2013). 2014. Accessed on March 2015. Available from: http://www.health.nsw.gov.au/Infectious/Influenza/Documents/2013/december-report.pdf
  20. Australian Government Department of Health and Ageing. Immunise Australia Program—Pneumococcal Disease. 2012. Accessed on 21 August 2014. Available from: www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-pneumococcal

Top of page

  1. Centers for Disease Control and Prevention. Measles. In: Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and prevention of vaccine preventable diseaseS. 12th edn. Washington, D.C.: Public Health Foundation; 2011.
  2. World Health Organization. Measles. Geneva; 2014.
  3. Strebel P, Papania M, Dayan G, Halsey N. VaccineS. Philadelphia: Saunders Elsevier; 2008.
  4. Gidding H, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, et al. Sustained measles elimination in Australia and priorities for long-term maintenance. Vaccine 2007;25(18):3574–3580.
  5. Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell 2001;25(3):133–136.
  6. Heywood AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009;87(1):64–71.
  7. de Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000;151:1039–1048.
  8. Plotkin SA. The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis 2006;43(Suppl 3):S164–S168.
  9. Gupta R, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ 2005;330:1132–1135.
  10. Deeks S, Lim G, Simpson M, Gagné L, Kristjanson E, Fung C, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. Can Med Assoc J 2011;183(9):1014–1020.
  11. Demicheli V, Rivetti A, Debalini M, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Chochrane Database Sys Rev 2012;2:CD004407.
  12. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358(15):1580–1589.
  13. Whelan J, Van Binnendijk R, Greenland K, Fanoy E, Kharqi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands. Euro Surveill 2010;15(17):pii:19554.
  14. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis 2007;13(1):12–17.
  15. Pertussis. In: Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and prevention of vaccine preventable diseaseS. 12th edn. Washington, DC: Public Health Foundation, Centers for Disease Control and Prevention; 2011.
  16. NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2012: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2015;39(1):E46–E136.
  17. Quinn H, McIntyre PB. Impact of removal of the 18 month DTPa dose on pertussis vaccine effectiveness. In: 12th National Immunisation Conference. Adelaide, South Australia; 2010.
  18. Sheridan SL, McCall BJ, Davis CA, Robson JM, Hull BP, Selvey CE, et al. Acellular pertussis vaccine effectiveness for children during the 2009–2010 pertussis epidemic in Queensland. Med J Aust 2014;200(6):334–338.
  19. Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014;133(3):e513–e519.
  20. Wendelboe AM, van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24(5 Suppl):S58–S61.

Top of page

  1. Communicable Diseases Network Australia. Series of National Guidelines – Pertussis. 2013. Accessed on March 2015. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-pertussis.htm
  2. Munoz FM. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis 2006;17(1):14–19.
  3. Song N, Gao Z, Wood J, Hueston L, Gilbert C, MacIntyre R, et al. Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination. Vaccine 2012;30:4073–4078.
  4. Twenty-second Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region; 2013.
  5. Western Pacific Regional Office. Rubella and congenital rubella syndrome In: Organization WH, editor. Geneva: World Health Organization; 2012.
  6. Marin M, Güris D, Chaves S, Schmid S, Seward J. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP): Centers for Disease Control and Prevention (CDC); 2007.
  7. Mackenzie JS, Lindsay MD, Coelen RJ, Broom AK, Hall RA, Smith DW. Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 1994;136(3–4):447–467.
  8. Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect 2000;2(14):1693–1704.
  9. Knope K, Whelan P, Smith D, Johansen C, Moran R, Doggett S, et al. Arboviral diseases and malaria in Australia, 2010–11: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell 2013;37(1):E1–E20.
  10. Viennet E, Knope K, Faddy HM, Williams CR, Harley D. Assessing the threat of chikungunya virus emergence in Australia. Commun Dis Intell 2013;37(2):E136–E143.
  11. Therapeutic Goods Administration. Product recall, Panbio Barmah Forest Virus IgM ELISA. An in vitro diagnostic medical device (IVD). Recall no. RC-2013-RN-00967-1,13/09/2013. 2013. Accessed on 6 May 2014. Available from: http://www.tga.gov.au/SARA/arn-detail.aspx?k=RC-2013-RN-00967-1
  12. Dingle KE, Colles FM, Ure R, Wagenaar JA, Duim B, Bolton FJ, et al. Molecular characterization of Campylobacter jejuni clones: a basis for epidemiologic investigation. Emerg Infect Dis 2002;8(9):949–955.
  13. Guzman MG, Kouri G, Martinez E, Bravo J, Riveron R, Soler M, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 1987;21(3):270–279.
  14. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181(1):2–9.
  15. Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004;10(12 Suppl):S98–S109.
  16. Hanna JN, Ritchie SA, Richards AR, Humphreys JL, Montgomery BL, Ehlers GJ, et al. Dengue in north Queensland, 2005–2008. Commun Dis Intell 2009;33(2):198–203.
  17. Queensland Health. Queensland Dengue Management Plan 2010–2015, 2011. Queensland: Queensland Health.
  18. Queensland Health. Queensland Health Weekly Notifiable Conditions data. Accessed on 7 August 2015. Available from: https://www.health.qld.gov.au/ph/cdb/sru_data.asp
  19. Department of Health Western Australia. Locally-acquired dengue fever case confirmed in the Pilbara. 2013. Accessed on 7 August 2013. Available from: http://www.health.wa.gov.au/press/view_press.cfm?id=1366
  20. Knope K, National Arbovirus and Malaria Advisory Committee, Giele, C. Increasing notifications of dengue related to overseas travel, 1991 to 2012. Commun Dis Intell 2013;37(1):E55–E59.

Top of page

  1. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, et al. Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 1999;170:533–536.
  2. Knox J, Cowan RU, Doyle JS, Ligtermoet MK, Archer JS, Burrow JN, et al. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust 2012;196(5):322–326.
  3. Roche SE, Wicks R, Garner MG, East IJ, Paskin R, Moloney BJ, et al. Descriptive overview of the 2011 epidemic of arboviral disease in horses in Australia. Aust Vet J 2013;91(1–2):5–13.
  4. Frost MJ, Zhang J, Edmonds JH, Prow NA, Gu X, Davis R, et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis 2012;18(5):792–800.
  5. Cox-Singh J, Davis TM, Lee KS, Shamsul SS, Matusop A, Ratnam S, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008;46(2):165–171.
  6. World Health Organization. Synopsis of the world malaria situation in 1981. Wkly Epidemiol Rec 1983;58(26):197–199.
  7. Leder K, Torresi J, Brownstein JS, Wilson ME, Keystone JS, Barnett E, et al. Travel-associated illness trends and clusters, 2000–2010. Emerg Infect Dis 2013;19(7):1049–1073.
  8. Gray TJ, Trauer JM, Fairley M, Krause VL, Markey PG. Imported malaria in the Northern Territory, Australia—428 consecutive cases. Commun Dis Intell 2012;36(1):107–113.
  9. Hanna JN, Ritchie SA, Eisen DP, Cooper RD, Brookes DL, Montgomery BL. An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. Med J Aust 2004;180(1):24–28.
  10. Preston-Thomas A, Gair RW, Hosking KA, Devine GJ, Donohue SD. An outbreak of Plasmodium falciparum malaria in the Torres Strait. Commun Dis Intell 2012;36(2):E180–E185.
  11. World Health Organization. Zoonoses. Technical report series no. 169. Geneva, Switzerland: World Health Organization; 1959.
  12. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 2001;356(1411):983–989.
  13. Jones KE, Patel NG, Levy MA. Global trends in emerging infectious diseases. Nature 2008(451):990–994.
  14. Woolhouse MEJ, Gowtage-Sequeria S. Host range and emerging and re-emerging pathogens. Emerg Infect Dis 2005;11(12):1842–1847.
  15. World Health Organization. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases. Geneva, Switzerland: World Health Organization; 2004.
  16. Animal Health Australia. Animal Health in Australia, 2013. In: Animal Health Australia, Canberra.
  17. Kolbe A, Yuen M, Doyle B. A case of human cutaneous anthrax. Med J Aust 2006;185(5):281–282.
  18. Fielding J. Zoonoses: Anthrax. Victorian Infectious Diseases Bulletin 2007;10(2):47.
  19. NSW Department of Health. Communicable Diseases Report, NSW, January and February 2010. N S W Public Health Bull 2010;21(3–4):103–107.
  20. Calisher CH, Ellison JA. The other rabies viruses: The emergence and importance of lyssaviruses from bats and other vertebrates. Travel Med Infect Dis 2012;10(2):69–79.

Top of page

  1. Fraser GC, Hooper PT, Lunt RA, Gould AR, Gleeson LJ, Hyatt AD, et al. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerg Infect Dis 1996;2(4):327–331.
  2. Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, Gleeson LJ, et al. A new lyssavirus — the first endemic rabies-related virus recognized in Australia. Bulletin de l’Institut Pasteur 1997;95(4):209–218.
  3. Communicable Diseases Network Australia. Series of National Guidelines: Rabies virus and other lyssavirus including Australian bat lyssavirus) exposures and infections. 2013. Accessed on 7 June 2013. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-abvl-rabies.htm
  4. Francis JR, Nourse C, Vaska VL, Calvert S, Northill JA, McCall B, et al. Australian bat lyssavirus in a child: The first reported case. Pediatrics 2014;133(4):e1063–1067.
  5. Queensland Department of Agriculture. Australian bat lyssavirus overview. In: Animal Health and Diseases: Queensland Government; 2013.
  6. Crook A. Australian bat lyssavirus communiqué. In: Department of Agriculture, Fisheries and Forestry; 2013.
  7. Allworth A, Murray K, Morgan J. A human case of encephalitis due to a lyssavirus recently identified in fruit bats. Commun Dis Intell 1996;20(24):504.
  8. Hanna JN, Carney IK, Smith GA, Tannenberg AEG, Deverill JE, Botha JA, et al. Australian bat lyssavirus infection: a second human case, with long incubation period. Med J Aust 2000;172(12):597–599.
  9. Australian Bat Lyssavirus Focus Group. ABLV Bat Stats, Australian Bat Lyssavirus report – December 2013. Australian Wildlife Health Network 2013.
  10. Animal Health Australia. Animal Health in Australia 2012. Canberra; 2013.
  11. Eales KM, Norton RE, Ketheesan N. Brucellosis in northern Australia. Am J Trop Med Hyg 2010;83(4):876–878.
  12. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14(2):296–326.
  13. World Health Organization. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva, Switzerland: World Health Organization; 2003.
  14. O’Leary FM, Hunjan JS, Bradbury R, Thanakrishnan G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004;180(1):29–31.
  15. Beeckman DS, Vanrompay DC. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clin Microbiol Infect 2009;15(1):11–17.
  16. Deschuyffeleer TP, Tyberghien LF, Dickx VL, Geens T, Saelen JM, Vanrompay DC, et al. Risk assessment and management of Chlamydia psittaci in poultry processing plants. Ann Occup Hyg 2012;56(3):340–349.
  17. McCaul TF, Williams JC. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 1981;147(3):1063–1076.
  18. Lowbridge CP, Tobin S, Seale H, Ferson MJ. Notifications of Q fever in NSW, 2001–2010. N S W Public Health Bull 2012;23(1–2):31–35.
  19. Bell M, Patel M, Sheridan J. Q fever vaccination in Queensland abattoirs. Commun Dis Intell 1997;21(3):29–31.
  20. Lin M, Delpech V, McAnulty J, Campbell-Lloyd S. Notifications of Q fever in New South Wales, 1991–2000: EpiReview. N S W Public Health Bull 2001;12(6):172–175.

Top of page

  1. Gidding HF, Wallace C, Lawrence GL, McIntyre PB. Australia’s National Q Fever Vaccination Program. Vaccine 2009;27(14):2037–2041.
  2. Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev 2002;15(4):631–646.
  3. Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, et al. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis 2012;18(9):1484–1486.
  4. Veitch M. The public health response to tularemia in Tasmania. In: Communicable Diseases Control Conference 2013. Canberra, Australia; 2013.
  5. de Jong B. Legionella, springtime and potting soils. Euro Surveill 2010;15(8):19497.
  6. O’Connor BA, Carman J, Eckert K, Tucker G, Givney R, Cameron S. Does potting mix make you sick? Results for a Legionella longbeachae case-control study in South Australia. Epidemiol Infect 2007;135(1):34–39.
  7. Pravinkumar SJ, Edwards G, Lindsay D, Redmond S, Stirling J, House R, et al. A cluster of Legionnaires’ disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008–2009. Euro Surveill 2010;15(8):19496.
  8. Whiley H, Bentham R. Legionella longbeachae and legionellosis. Emerg Infect Dis 2011;17(4):579–583.
  9. Queensland Health. Review of the prevention and control of Legionella pneumophila infection in Queensland: Chief Health Officer’s report, September 2013. Brisbane: Queensland Health; 2013.
  10. Li J, O’Brien ED, Guest C. A review of national legionellosis surveillance in Australia, 1991 to 2000. Commun Dis Intell 2002;26:462–470.
  11. Rota MC, Caporal MG, Bella A, Ricci ML, Napoli C. Legionnaires disease in Italy: results of the epidemiological surveillance from 2000 to 2011. Euro Surveill 2013;18(23).
  12. World Health Organization. Leprosy – Fact Sheet. 2014. Available from: http://www.who.int/mediacentre/factsheets/fs101/en/
  13. Communicable Diseases Network Australia. Guidelines for the early clinical and public health management of meningococcal disease in Australia. Revised 2007. Accessed on 6 November 2013. Available from: http://webarchive.nla.gov.au/gov/20140801082945/http://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-other-mening-2007.htm
  14. Communicable Diseases Network Australia. Surveillance Case Definitions for the Australian National Notifiable Diseases Surveillance System. 2004. Accessed on 25 June 2012. Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_mening.htm
  15. Bareja C, Waring J, Stapledon R, National Tuberculosis Advisory Committee for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2010. Commun Dis Intell 2014;38(1):E36–E48.
  16. Luca S, Mihaescu T. History of BCG vaccine. Maedica (Buchar) 2013;8(1):53–58.
  17. Public Health England. Tuberculosis: the green book, chapter 32. In: Immunisation against infectious disease London: Department of Health; 2013. p. 394.
  18. National Tuberculosis Advisory Committee. The BCG vaccine: Information and recommendations for use in Australia. Commun Dis Intell 2013;37(1):E65–E72.

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now